This Week’s Biopharma News: New Pharma Legislation in Europe
December 16, 2025
Our latest news roundup reports on the oversubscribed financing for Cellular Origins, FDA approval for Amgen, CAR-T cell therapy outcomes, and more
5 min read
False
Advertisement
Industry News
Scratching the Surface of Microneedle Array Patches
By Andrew Riso
December 12, 2025
Why the industry should open its eyes to the benefits of microneedle array patches for drug delivery.
5 min read
Rebuilding Confidence in UK Pharma Manufacturing
By Martyn Williams
December 11, 2025
The UK’s pharma manufacturing base still has potential, but only if companies modernize operations, boost efficiency, and show global investors that the UK can compete on cost and capability.
6 min read
This Week’s CGT News: Vertex’s Gene Therapies Show Promise in Younger Children
December 10, 2025
Our latest news roundup reports on new data for Vertex’s exa-cel, funding for a cell therapy for breast cancer, and new technologies for manufacturing
3 min read
This Week’s CGT News: Advancing Mitochondrial Therapy
December 2, 2025
Our latest news roundup reports on a partnership to bring cell and gene therapies to underserved communities in India, a new biotech using AI to improve gene editing, and more
4 min read
Discussing the Big Ideas in Medicine Manufacturing
November 27, 2025
A group of experts share their thoughts on the next “big ideas” that they think will shape the near future of therapy developments.
6 min read
Breaking Down Barriers to Biosimilar Access
November 26, 2025
With new approvals for its denosumab biosimilars, Biocon Biologics is working to close gaps in access across Europe...
6 min read
This Week’s Biopharma News: New Restrictions on Sarepta Gene Therapy
November 18, 2025
Our latest news roundup reports on the FDA’s new “plausible mechanism” pathway, Novartis’s phase III malaria trial, a new gene therapy in Europe, and more.
4 min read
This Week’s Biopharma News: Clinical Hold for Heart Disease Gene Therapy
November 12, 2025
Our latest news roundup reports on Novartis’ new radioligand facility in California, new tech for boosting AAV yields, and MeiraGTx’s deal with Eli Lilly
4 min read
Promising Early Results in Solid Tumor Trial
November 11, 2025
Lyell Immunopharma acquires rights to CAR T cell therapy for solid tumors
2 min read
